Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Dusseldorf - Delayed Quote EUR

PharmaSGP Holding SE (PSG.DU)

Compare
23.80
+0.20
+(0.85%)
At close: April 4 at 7:30:35 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
114,000
101,099
85,824
65,344
63,246
Cost of Revenue
10,333
9,462
9,032
6,488
6,206
Gross Profit
103,667
91,637
76,792
58,856
57,040
Operating Expense
76,911
66,999
59,109
43,937
40,966
Operating Income
26,756
24,638
17,683
14,919
16,074
Net Non Operating Interest Income Expense
-2,457
-3,533
-2,094
-713
-99
Pretax Income
25,087
21,893
15,803
14,206
14,149
Tax Provision
6,288
5,496
3,849
3,516
3,509
Net Income Common Stockholders
18,799
16,397
11,954
10,690
10,640
Diluted NI Available to Com Stockholders
18,799
16,397
11,954
10,690
10,640
Basic EPS
1.57
1.37
1.00
0.89
0.89
Diluted EPS
1.57
1.37
1.00
0.89
0.89
Basic Average Shares
11,992.86
11,992.64
12,000
12,000
12,000
Diluted Average Shares
11,992.86
11,992.64
12,000
12,000
12,000
Total Expenses
87,244
76,461
68,141
50,425
47,172
Net Income from Continuing & Discontinued Operation
18,799
16,397
11,954
10,690
10,640
Normalized Income
18,208.51
15,806.79
11,792.22
10,690
12,012.39
Interest Income
1,139
235
47
--
5
Interest Expense
4,238
4,410
2,007
642
75
Net Interest Income
-2,457
-3,533
-2,094
-713
-99
EBIT
29,325
26,303
17,810
14,848
14,224
EBITDA
38,726
35,674
27,060
18,421
14,710
Reconciled Cost of Revenue
10,333
9,462
9,032
6,488
6,206
Reconciled Depreciation
9,401
9,371
9,250
3,573
486
Net Income from Continuing Operation Net Minority Interest
18,799
16,397
11,954
10,690
10,640
Total Unusual Items Excluding Goodwill
788
788
214
--
-1,825
Total Unusual Items
788
788
214
--
-1,825
Normalized EBITDA
37,938
34,886
26,846
18,421
16,535
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
197.51
197.79
52.22
--
-452.61
12/31/2020 - 6/19/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PB8.MU Phibro Animal Health Corp
17.95
-4.01%
 
MRK.MU Merck KGaA
122.50
-1.76%
 
FFEA.MU Faes Farma SA
4.0100
+1.52%
 
M5B.SG
 
UVP.MU AusCann Group Holdings Ltd
0.0280
0.00%
 
PB8.SG Phibro Animal Health Corp
17.20
-4.44%
 
UVP.SG AusCann Group Holdings Ltd
0.0260
0.00%
 
HM6A.SG Hypera S.A.
2.6600
-1.48%
 
GU5.SG Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
1.9800
-0.50%
 
MRKC.DU Merck KGaA
22.80
-4.20%